Health
Host tissue T cells play a previously unappreciated role in acute graft-versus-host disease – News-Medical.net
Allogenic hematopoietic stem cell transplantation (HSCT) is a procedure that infuses a donor’s healthy blood-forming stem cells into a recipient as part of a potentially curative therapy for cancer.
Reviewed by Emily Henderson, B.Sc.Aug 28 2020
Allogenic hematopoietic stem cell transplantation (HSCT) is a procedure that infuses a donor’s healthy blood-forming stem cells into a recipient as part of a potentially curative therapy for cancer. While this therapy can be life-saving, a major complication is the development of graft-versus-host disease (GVHD), which causes significant morbidity and can be fatal. Before allogenic HSCT, a patient receives a conditioning regimen, chemotherapy design…
-
Noosa News20 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man
-
General22 hours agoTrial of celebrity crocodile wrangler Matt Wright to hear from more witnesses
-
General23 hours agoPM kicks off roundtable with call for lasting reform
-
Noosa News21 hours agoMan dead after breaking into childcare centre